ReachMD
Be part of the knowledge.™Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 1-15 of 211
- 1
ACC Action Center
Beginning of an Era: Treatment of Elevated Lp(a)
Beginning of an Era: Treatment of Elevated Lp(a)
- 1
ACC Action Center
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
- 1
ACC Action Center
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
- 1
ACC Action Center
Novel Form of CV Research with Dietary Education in the Grocery Store
Novel Form of CV Research with Dietary Education in the Grocery Store
- 1
ACC Action Center
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
- 1
ACC Action Center
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
- 1
ACC Action Center
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
- 1
ACC Action Center
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
- 1
ACC Action Center
Impact of New First-in-Class Medical Therapy in Obstructive HCM
Impact of New First-in-Class Medical Therapy in Obstructive HCM
- 1
ACC Action Center
Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
- 1
ACC Action Center
PCSK9i Reduces Plaque Burden in Coronary Arteries
PCSK9i Reduces Plaque Burden in Coronary Arteries
- 1
ACC Action Center
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
- 0
Project Oncology®
Beyond the Data: Key Takeaways on Breast Cancer Therapies from SABCS 2021
Beyond the Data: Key Takeaways on Breast Cancer Therapies from SABCS 2021
